The effect of bile acid hydrophobicity on nucleation of several types of cholesterol crystals from model bile vesicles. 1994

M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
Department of Gastroenterology, University Hospital Utrecht, The Netherlands.

Nucleation of cholesterol crystals is thought to occur from cholesterol-phospholipid vesicles. We tested the hypothesis that bile acids are necessary for nucleation of cholesterol crystals. Model bile vesicles were prepared by KBr density ultracentrifugation of supersaturated model bile and mixed with one of the following bile acids: ursodeoxycholate, taurocholate, cholate, chenodeoxycholate or deoxycholate in final concentrations of 3, 30 and 100 mM. Vesicles were also mixed with various combinations of ursodeoxycholate and deoxycholate. Nucleation was assessed semi-quantitatively with polarizing microscopy. After 5 days, samples were again subjected to ultracentrifugation. Addition of 3 and 30 mM taurocholate, cholate, chenodeoxycholate and deoxycholate to vesicles induced nucleation. The extent of nucleation increased significantly with increasing bile acid hydrophobicity: deoxycholate > chenodeoxycholate > cholate > taurocholate (p < 0.05). At 100 mM bile acid this order was reversed (p < 0.05) because most of the cholesterol was solubilized in micelles as shown by ultracentrifugation after 5 days. Percentages of vesicular cholesterol decreased with increasing hydrophobicity: deoxycholate < chenodeoxycholate < cholate < taurocholate (p < 0.05). Ursodeoxycholate did not induce nucleation. At least seven cholesterol crystal shapes could be distinguished and all crystal types could be found after addition of various combinations of ursodeoxycholate+deoxycholate. We conclude that in this model: (a) bile acid species play an important role in the precipitation of cholesterol crystals from model bile vesicles; (b) the more hydrophobic bile acids induce more cholesterol crystal precipitation; and (c) the hydrophobicity of bile acids influences cholesterol crystal morphology.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008823 Micelles Particles consisting of aggregates of molecules held loosely together by secondary bonds. The surface of micelles are usually comprised of amphiphatic compounds that are oriented in a way that minimizes the energy of interaction between the micelle and its environment. Liquids that contain large numbers of suspended micelles are referred to as EMULSIONS. Micelle
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D014461 Ultracentrifugation Centrifugation with a centrifuge that develops centrifugal fields of more than 100,000 times gravity. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
May 1995, Zhonghua yi xue za zhi,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
February 1991, Journal of lipid research,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
September 1990, Hepatology (Baltimore, Md.),
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
April 1989, Journal of lipid research,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
January 1989, Journal of lipid research,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
September 1987, Biochimica et biophysica acta,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
August 1996, The Biochemical journal,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
July 1996, European journal of clinical investigation,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
July 1987, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
M F Stolk, and B J van de Heijning, and K J van Erpecum, and A M van den Broek, and W Renooij, and G P van Berge-Henegouwen
April 2011, Steroids,
Copied contents to your clipboard!